Stephen Liu, Director of Thoracic Oncology, Chief of the Division of Hematology and Oncology, and Associate Professor at Georgetown Lombardi Comprehensive Cancer Center, shared on X:
“FINALLY! AstraZeneca reaches deal with Dizal to bring sunvozertinib to the US!
Approved for EGFR exon 20 NSCLC over a year ago but only available in China (and at a different dose). This deal comes off phase 3 WU-KONG28 showing superiority over 1L chemo.”
Other articles featuring Dr. Liu on OncoDaily.